Integrated Wealth Management (Palm Desert)’s iShares Biotechnology ETF IBB Stock Holding History

Integrated Wealth Management (Palm Desert)’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$367K	Sell	3,756 -345	-8%	-$33K	0.12%	165
2016 Q4	$363K	Sell	4,101 -1,347	-25%	-$123K	0.14%	157
2016 Q3	$526K	Buy	5,448 +1,041	+24%	+$99K	0.19%	119
2016 Q2	$378K	Buy	4,407 +579	+15%	+$52K	0.15%	141
2016 Q1	$333K	Buy	3,828 +891	+30%	+$79.7K	0.14%	129
2015 Q4	$331K	Buy	2,937 +486	+20%	+$52.7K	0.14%	127
2015 Q3	$248K	Buy	2,451 +1,338	+120%	+$160K	0.11%	156
2015 Q2	$137K	Buy	1,113 +777	+231%	+$93K	0.05%	241
2015 Q1	$38K	Buy	+336	New	+$37.1K	0.02%	435

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Integrated Wealth Management (Palm Desert)'s IBB Position: Q1 2017 in Review

Integrated Wealth Management (Palm Desert) reduced its iShares Biotechnology ETF (IBB) stake by 8.4% in Q1 2017, selling an estimated $33K and leaving 3,756 shares worth $367K. The position accounts for 0.12% of the portfolio, ranked #165.

Integrated Wealth Management (Palm Desert) first reported a position in IBB in Q1 2015 and has held it in 9 quarters since. The position peaked at $526K in Q3 2016. 521 funds tracked by Wall St. Rank hold IBB as of Q1 2017.

Integrated Wealth Management (Palm Desert) held 3,756 shares of iShares Biotechnology ETF worth $367K as of Q1 2017.
Integrated Wealth Management (Palm Desert) sold 345 iShares Biotechnology ETF shares in Q1 2017, an estimated $33K.
iShares Biotechnology ETF made up 0.12% of Integrated Wealth Management (Palm Desert)'s portfolio in Q1 2017, its #165 holding.
Integrated Wealth Management (Palm Desert) first reported a position in iShares Biotechnology ETF in Q1 2015 and has held it in 9 quarters since.
Integrated Wealth Management (Palm Desert)'s iShares Biotechnology ETF position peaked at $526K in Q3 2016.
521 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2017.

Based on Integrated Wealth Management (Palm Desert)'s 13F filing for Q1 2017, filed 14 Apr 2017.